Apellis Pharmaceuticals Stock Statistic Functions Beta
| APLS Stock | USD 30.00 2.25 8.11% |
| Symbol |
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Apellis Pharmaceuticals correlated with the market. If Beta is less than 0 Apellis Pharmaceuticals generally moves in the opposite direction as compared to the market. If Apellis Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Apellis Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Apellis Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Apellis Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
Apellis Pharmaceuticals Technical Analysis Modules
Most technical analysis of Apellis Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Apellis from various momentum indicators to cycle indicators. When you analyze Apellis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Apellis Pharmaceuticals Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Apellis Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Apellis Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Apellis Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Apellis Pharmaceuticals's daily price indicators and compare them against related drivers, such as statistic functions and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Apellis Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for Apellis Pharmaceuticals, we also check how macroeconomic factors affect Apellis Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 55.4 | 37.39 | 190.0 | 199.5 | PTB Ratio | 20.09 | 32.3 | 36.52 | 19.3 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Apellis Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Apellis Pharmaceuticals' short interest history, or implied volatility extrapolated from Apellis Pharmaceuticals options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Entertainment Invested over 90 shares | |
 | Macroaxis Index Invested few shares | |
 | Momentum Invested over 60 shares | |
 | Hedge Favorites Invested over 100 shares | |
 | Banking Invested over 20 shares | |
 | Baby Boomer Prospects Invested over 40 shares | |
 | Cash Cows Invested few shares | |
 | Macroaxis Picks Invested over 30 shares | |
 | Warren Buffett Holdings Invested few shares | |
 | ESG Investing Invested few shares |
Additional Tools for Apellis Stock Analysis
When running Apellis Pharmaceuticals' price analysis, check to measure Apellis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apellis Pharmaceuticals is operating at the current time. Most of Apellis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Apellis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apellis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Apellis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.